Difference between revisions of "Template:Ionotropic glutamate receptor modulators"
Jump to navigation
Jump to search
imported>Medgirl131 |
imported>Medgirl131 |
||
| (6 intermediate revisions by 5 users not shown) | |||
| Line 3: | Line 3: | ||
| title = [[Ionotropic glutamate receptor]] [[receptor modulator|modulator]]s | | title = [[Ionotropic glutamate receptor]] [[receptor modulator|modulator]]s | ||
| state = {{{state<includeonly>|collapsed</includeonly>}}} | | state = {{{state<includeonly>|collapsed</includeonly>}}} | ||
| − | | | + | | bodyclass = hlist |
| groupstyle = text-align:center; | | groupstyle = text-align:center; | ||
| Line 18: | Line 18: | ||
* [[Quisqualic acid]] | * [[Quisqualic acid]] | ||
* [[Willardiine]]; ''Positive allosteric modulators:'' [[Aniracetam]] | * [[Willardiine]]; ''Positive allosteric modulators:'' [[Aniracetam]] | ||
| + | * [[BIIB-104|BIIB-104 (PF-04958242)]] | ||
* [[Cyclothiazide]] | * [[Cyclothiazide]] | ||
* [[CX-516]] | * [[CX-516]] | ||
| Line 39: | Line 40: | ||
* [[Oxiracetam]] | * [[Oxiracetam]] | ||
* [[PEPA (drug)|PEPA]] | * [[PEPA (drug)|PEPA]] | ||
| − | |||
* [[Piracetam]] | * [[Piracetam]] | ||
* [[Pramiracetam]] | * [[Pramiracetam]] | ||
| Line 162: | Line 162: | ||
* [[Epipregnanolone sulfate]] | * [[Epipregnanolone sulfate]] | ||
* [[Pregnenolone sulfate]] | * [[Pregnenolone sulfate]] | ||
| + | * [[SAGE-201]] | ||
| + | * [[SAGE-301]] | ||
* [[SAGE-718]] | * [[SAGE-718]] | ||
| Line 332: | Line 334: | ||
* [[Bumetanide]] | * [[Bumetanide]] | ||
* [[Caroverine]] | * [[Caroverine]] | ||
| + | * [[Conantokin]] | ||
* [[D-α-Aminoadipate|<small>D</small>-αAA]] | * [[D-α-Aminoadipate|<small>D</small>-αAA]] | ||
* [[Dexanabinol]] | * [[Dexanabinol]] | ||
| Line 352: | Line 355: | ||
* [[Transcrocetin]] ([[saffron]]) | * [[Transcrocetin]] ([[saffron]]) | ||
| − | + | * '''Unsorted:''' ''Allosteric modulators:'' [[AGN-241751]] | |
| + | |below = | ||
| + | * '''''See also:''' [[Template:Receptor modulators|Receptor/signaling modulators]]'' | ||
| + | * ''[[Template:Metabotropic glutamate receptor modulators|Metabotropic glutamate receptor modulators]]'' | ||
| + | * ''[[Template:Glutamate metabolism and transport modulators|Glutamate metabolism/transport modulators]]'' | ||
}} | }} | ||
<noinclude> | <noinclude> | ||
| − | {{ | + | {{Collapsible option}} |
[[Category:Drug templates by receptor, channel, or pump]] | [[Category:Drug templates by receptor, channel, or pump]] | ||
</noinclude> | </noinclude> | ||
Latest revision as of 17:35, 1 August 2018
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Ionotropic glutamate receptor modulators|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Ionotropic glutamate receptor modulators|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Ionotropic glutamate receptor modulators|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.